Evidence map›Paper›PMID 22389487›Full record

ArticleJournal of bacteriology2012

TprC/D (Tp0117/131), a trimeric, pore-forming rare outer membrane protein of Treponema pallidum, has a bipartite domain structure.

Arvind Anand, Amit Luthra, Star Dunham-Ems, Melissa J Caimano, Carson Karanian, Morgan LeDoyt, Adriana R Cruz, Juan C Salazar, Justin D Radolf

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 50 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Review
  3. Article
  4. In-Depth Proteome Coverage of In Vitro-CulturedJournal of proteome research · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immunotopological Analysis of theJournal of bacteriology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Syphilis.Nature reviews. Disease primers · 2017
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Arvind AnandDepartments of Medicine, University of Connecticut Health Center, Farmington, Connecticut, USA.
Amit Luthra
Star Dunham-Ems
Melissa J Caimano
Carson Karanian
Morgan LeDoyt
Adriana R Cruz
Juan C Salazar
Justin D Radolf
UConn Health · USConnecticut Children's Medical Center · USCentro Internacional de Entrenamiento e Investigaciones Medicas · CO

Funding

Treponema pallidum Outer Membrane Proteins and Transition Metal AcquisitionR01AI026756 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D · 1992 to 2017
$5.1M
T.pallidum Membrane Immunogens and Anti-Oxidant DefenseR37AI026756 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RADOLF, JUSTIN D · 2002 to 2006
$1.8M
Immunity in Early Syphillis: Pathway to HIV CoinfectionK23AI062439 · NIAID · CONNECTICUT CHILDREN'S MEDICAL CENTER · PI SALAZAR, JUAN C · 2005 to 2007
$454k
Systemic Innate Immune Responses in Secondary SyphilisR03TW008023 · FIC · CONNECTICUT CHILDREN'S MEDICAL CENTER · PI SALAZAR, JUAN C · 2008 to 2010
$116k
MEMBRANE PROTEINS OF TREPONEMA PALLIDUMR29AI026756 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D. · 1988 to 1991
–
FIC NIH HHS 5R03TW008023FIC NIH HHS 5R03TW008023-3FIC NIH HHS R03 TW008023NIAID NIH HHS AI-26756NIAID NIH HHS K23 AI062439NIAID NIH HHS K23 AI62439NIAID NIH HHS R01 AI026756NIAID NIH HHS R37 AI026756
6 · The paper itself

Abstract

Identification of Treponema pallidum rare outer membrane proteins (OMPs) has been a longstanding objective of syphilis researchers. We recently developed a consensus computational framework that employs a battery of cellular localization and topological prediction tools to generate ranked clusters of candidate rare OMPs (D. L. Cox et al., Infect. Immun. 78:5178-5194, 2010). TP0117/TP0131 (TprC/D), a member of the T. pallidum repeat (Tpr) family, was a highly ranked candidate. Circular dichroism, heat modifiability by SDS-PAGE, Triton X-114 phase partitioning, and liposome incorporation confirmed that full-length, recombinant TprC (TprC(Fl)) forms a β-barrel capable of integrating into lipid bilayers. Moreover, TprC(Fl) increased efflux of terbium-dipicolinic acid complex from large unilamellar vesicles and migrated as a trimer by blue-native PAGE. We found that in T. pallidum, TprC is heat modifiable, trimeric, expressed in low abundance, and, based on proteinase K accessibility and opsonophagocytosis assays, surface exposed. From these collective data, we conclude that TprC is a bona fide rare OMP as well as a functional ortholog of Escherichia coli OmpF. We also discovered that TprC has a bipartite architecture consisting of a soluble N-terminal portion (TprC(N)), presumably periplasmic and bound directly or indirectly to peptidoglycan, and a C-terminal β-barrel (TprC(C)). Syphilitic rabbits generate antibodies exclusively against TprC(C), while secondary syphilis patients fail to mount a detectable antibody response against either domain. The syphilis spirochete appears to have resolved a fundamental dilemma arising from its extracellular lifestyle, namely, how to enhance OM permeability without increasing its vulnerability to the antibody-mediated defenses of its natural human host.

Indexed as

AnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsCloning, MolecularGene Expression Regulation, BacterialHot TemperatureHumansPolysaccharidesProtein ConformationProtein FoldingRabbitsRecombinant ProteinsSyphilisTreponema pallidumAntibodies, BacterialBacterial Outer Membrane ProteinsPolysaccharidesRecombinant Proteins

Identifiers

PMID22389487
PMCPMC3347077
OpenAlexW2141206385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.